These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26874280)

  • 21. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
    Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
    Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI.
    Ye F; Wu X; Jeong EK; Jia Z; Yang T; Parker D; Lu ZR
    Bioconjug Chem; 2008 Dec; 19(12):2300-3. PubMed ID: 19053180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
    Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ 3 integrin.
    Debergh I; Van Damme N; De Naeyer D; Smeets P; Demetter P; Robert P; Carme S; Pattyn P; Ceelen W
    Ann Surg Oncol; 2014 Jun; 21(6):2097-104. PubMed ID: 24356800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis.
    Yan F; Xu X; Chen Y; Deng Z; Liu H; Xu J; Zhou J; Tan G; Wu J; Zheng H
    Ultrasound Med Biol; 2015 Oct; 41(10):2765-73. PubMed ID: 26166460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma.
    Patil R; Galstyan A; Grodzinski ZB; Shatalova ES; Wagner S; Israel LL; Ding H; Black KL; Ljubimova JY; Holler E
    Int J Nanomedicine; 2020; 15():3057-3070. PubMed ID: 32431501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and characterization of a porphyrazine-Gd(III) MRI contrast agent and in vivo imaging of a breast cancer xenograft model.
    Trivedi ER; Ma Z; Waters EA; Macrenaris KW; Subramanian R; Barrett AG; Meade TJ; Hoffman BM
    Contrast Media Mol Imaging; 2014; 9(4):313-22. PubMed ID: 24706615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadolinium(III) complex formation with a β-cyclodextrin ligand: an XAS study of a potential MRI contrast agent.
    Jalilehvand F; Homayonia S; Zhang P; Ling CC
    J Biol Inorg Chem; 2023 Dec; 28(8):805-811. PubMed ID: 37981582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment.
    Xu D; Lu ST; Li YS; Baidya A; Mei H; He Y; Wu B
    Drug Des Devel Ther; 2018; 12():3301-3309. PubMed ID: 30323562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.
    Li Y; Han Z; Roelle S; DeSanto A; Sabatelle R; Schur R; Lu ZR
    Mol Pharm; 2017 Nov; 14(11):3906-3915. PubMed ID: 28976766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative Molecular Imaging with a Single Gd-Based Contrast Agent Reveals Specific Tumor Binding and Retention in Vivo.
    Johansen ML; Gao Y; Hutnick MA; Craig SEL; Pokorski JK; Flask CA; Brady-Kalnay SM
    Anal Chem; 2017 Jun; 89(11):5932-5939. PubMed ID: 28481080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging.
    Yang X; Hong H; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Xiao Y; Yang Y; Zhang Y; Nickles RJ; Cai W; Steeber DA; Gong S
    Biomaterials; 2011 Jun; 32(17):4151-60. PubMed ID: 21367450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.
    Wu X; Burden-Gulley SM; Yu GP; Tan M; Lindner D; Brady-Kalnay SM; Lu ZR
    Bioconjug Chem; 2012 Aug; 23(8):1548-56. PubMed ID: 22812444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
    Lu ZR; Laney V; Li Y
    Acc Chem Res; 2022 Oct; 55(19):2833-2847. PubMed ID: 36121350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive monitoring of HPMA copolymer-RGDfK conjugates by magnetic resonance imaging.
    Zarabi B; Borgman MP; Zhuo J; Gullapalli R; Ghandehari H
    Pharm Res; 2009 May; 26(5):1121-9. PubMed ID: 19160028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted tumor MRI with gadobutrol-loaded anti-HER2 immunoliposomes.
    Chen W; Liu B; Chen J; Liu G; Liu X
    Acta Radiol; 2017 May; 58(5):573-580. PubMed ID: 27565629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of nanoglobule-cystamine-(Gd-DO3A), a biodegradable nanosized magnetic resonance contrast agent for dynamic contrast-enhanced magnetic resonance urography.
    Xu R; Kaneshiro TL; Jeong EK; Parker DL; Lu ZR
    Int J Nanomedicine; 2010 Sep; 5():707-13. PubMed ID: 20957222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
    Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.